Untitled 3

Source R&D is the authoritative source of technology and services information supporting pharmaceutical and biotechnology companies in their drug discovery and development research projects.

Source R&D features extensive listings of service providers classified under company or organisation type, including contract chemical manufacturers; contract biologics manufacturers; biological research companies and organisations; and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

The extensive coverage of Source R&D and the support of life sciences organisations One Nucleus and Bionow make it an invaluable reference tool that streamlines the vendor selection process to bring pharmaceutical/biotechnology companies and suppliers together.

Chemspace and LabNetwork collaborate to extend access to chemical databases

Online drug discovery chemicals marketplaces Chemspace and LabNetwork, a WuXi AppTec company, have entered into a collaboration agreement under which LabNetwork’s products will be available on www.chem-space.com, with distribution and technical support provided by Chemspace for European customers, thus expanding…
  • Published in Source R&D
  • Read: 43 times

FUJIFILM SonoSite launches redesigned SonoSite Institute

FUJIFILM SonoSite has launched itsnew redesigned version of the SonoSite Institute, a comprehensive online educational resource dedicated to empowering and educating health care providers about point-of-care ultrasound (POCUS). The company said that the enhanced website had taken account of feedback…

Simplifying high content screening with the VIAFLO 96

INTEGRA Biosciences’ VIAFLO 96 electronic multi-channel pipetting system is helping biotechnology company HCS Pharma to improve the reproducibility of high content screening using its patented BIOMIMESYS 3D cell culture technology. Elodie Vandenhaute, Study Director at HCS Pharma, explained: “96-well cell…
  • Published in Source R&D
  • Read: 202 times

Polyplus-transfection introduces new nanoparticle DNA transfection reagent

Polyplus-transfection SA, a developer of innovative solutions for the delivery of nucleic acids in research, bioproduction and therapeutics, has introduced jetOPTIMUS, a new reagent for powerful nanoparticle DNA transfection. “As cell and gene therapies become more advanced and complex, this…
  • Published in Source R&D
  • Read: 178 times
Subscribe to this RSS feed